Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors. | Front Oncol | 2023 | 37810965 | PubTator, text mining | PubMed |
| Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment. | J Exp Clin Cancer Res | 2023 | 37803464 | PubTator, text mining | PubMed |
| The potential and challenges of targeting MTAP-negative cancers beyond synthetic lethality. | Front Oncol | 2023 | 37795443 | PubTator, text mining | PubMed |
| Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study. | Leukemia | 2023 | 37794100 | PubTator, text mining | PubMed |
| A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo. | Nat Cancer | 2023 | 37783807 | PubTator, text mining | PubMed |
| Helicases in R-loop Formation and Resolution. | J Biol Chem | 2023 | 37778731 | PubTator, text mining | PubMed |
| Myeloid leukemia vulnerabilities embedded in long noncoding RNA locus MYNRL15. | iScience | 2023 | 37766974 | PubTator, text mining | PubMed |
| Impact of single versus multiple spliceosome mutations on myelodysplastic syndrome. | J Clin Exp Hematop | 2023 | 37766563 | PubTator, text mining | PubMed |
| Paroxysmal Nocturnal Hemoglobinuria: Biology and Treatment. | Medicina (Kaunas) | 2023 | 37763731 | PubTator, text mining | PubMed |
| FexSplice: A LightGBM-Based Model for Predicting the Splicing Effect of a Single Nucleotide Variant Affecting the First Nucleotide G of an Exon. | Genes (Basel) | 2023 | 37761905 | PubTator, text mining | PubMed |
| Exploring the Molecular Landscape of Myelofibrosis, with a Focus on Ras and Mitogen-Activated Protein (MAP) Kinase Signaling. | Cancers (Basel) | 2023 | 37760623 | PubTator, text mining | PubMed |
| Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies. | Cancers (Basel) | 2023 | 37760587 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to Small Molecules in Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 37760544 | PubTator, text mining | PubMed |
| HSP90 Inhibitor PU-H71 in Combination with BH3-Mimetics in the Treatment of Acute Myeloid Leukemia. | Curr Issues Mol Biol | 2023 | 37754227 | PubTator, text mining | PubMed |
| Evolutionary signatures of human cancers revealed via genomic analysis of over 35,000 patients. | Nat Commun | 2023 | 37749078 | PubTator, text mining | PubMed |
| Prognostic significance of TP53 and PIK3CA mutations analyzed by next-generation sequencing in breast cancer. | Medicine (Baltimore) | 2023 | 37747019 | PubTator, text mining | PubMed |
| BCR::ABL1-negative myeloproliferative neoplasms in the era of next-generation sequencing. | Front Genet | 2023 | 37745842 | PubTator, text mining | PubMed |
| U6 snRNA m6A modification is required for accurate and efficient cis- and trans-splicing of C. elegans mRNAs. | bioRxiv | 2023 | 37745402 | PubTator, text mining | PubMed |
| U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity. | Blood Cancer J | 2023 | 37735430 | PubTator, text mining | PubMed |
| Promoter R-Loops Recruit U2AF1 to Modulate Its Phase Separation and RNA Splicing. | J Am Chem Soc | 2023 | 37733759 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=18